Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.41B |
| 2 |
Microchip Technology
MCHP
|
+$691M |
| 3 |
Microsoft
MSFT
|
+$554M |
| 4 |
PepsiCo
PEP
|
+$534M |
| 5 |
Sunoco
SUN
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$649M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$490M |
| 3 |
NS
NuStar Energy L.P.
NS
|
+$431M |
| 4 |
Flutter Entertainment
FLUT
|
+$424M |
| 5 |
UDR
UDR
|
+$392M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.83% |
| 2 | Financials | 11.94% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 10.48% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Stereotaxis
STXS
$133M
| $47.9K | ﹤0.01% |
+26,327
| New | +$59K |
|
|
MOND
3727
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $47.5K | ﹤0.01% |
19,807
-366
| -2% | -$816 |
|
3728
AC Immune
ACIU
$241M
| $47.4K | ﹤0.01% |
+11,891
| New | +$39.3K |
|
3729
D-Wave Quantum Inc. Common Stock
QBTS
$6.66B
| $46.8K | ﹤0.01% |
+41,067
| New | +$57.9K |
|
3730
Acumen Pharmaceuticals
ABOS
$157M
| $45.9K | ﹤0.01% |
+18,986
| New | +$60.4K |
|
|
EVA
3731
DELISTED
Enviva Inc.
EVA
| $45.1K | ﹤0.01% |
104,809
| – | – |
|
|
CVAC
3732
DELISTED
CureVac
CVAC
| $43.9K | ﹤0.01% |
12,923
+1,628
| +14% | +$5.33K |
|
3733
Kaltura
KLTR
$206M
| $43.8K | ﹤0.01% |
36,517
-3
| -0% | -$4 |
|
3734
Dakota Gold
DC
$624M
| $42.8K | ﹤0.01% |
16,800
-932
| -5% | -$2.48K |
|
|
AMRN
3735
Amarin Corp
AMRN
$298M
| $40.8K | ﹤0.01% |
2,966
+469
| +19% | +$8.06K |
|
3736
AbCellera Biologics
ABCL
$1.74B
| $40.7K | ﹤0.01% |
13,743
+2,315
| +20% | +$8.76K |
|
3737
Cardiff Oncology
CRDF
$66.2M
| $40.4K | ﹤0.01% |
+18,180
| New | +$68.5K |
|
|
LNAI
3738
Lunai Bioworks
LNAI
$9.16M
| $40.2K | ﹤0.01% |
+287
| New | +$39.1K |
|
|
NOTE
3739
DELISTED
FiscalNote
NOTE
| $40K | ﹤0.01% |
2,284
-156
| -6% | -$2.47K |
|
3740
Invivyd
IVVD
$171M
| $39.5K | ﹤0.01% |
+35,894
| New | +$79.3K |
|
3741
PDS Biotechnology
PDSB
$39.1M
| $38.6K | ﹤0.01% |
13,174
-5,355
| -29% | -$17.1K |
|
|
GBIO
3742
DELISTED
Generation Bio
GBIO
| $37.7K | ﹤0.01% |
1,335
-208
| -13% | -$6.76K |
|
|
LUNA
3743
DELISTED
Luna Innovations Incorporated
LUNA
| $37.6K | ﹤0.01% |
11,754
-23,295
| -66% | -$69.1K |
|
|
OPTN
3744
DELISTED
OptiNose
OPTN
| $37.5K | ﹤0.01% |
2,405
+265
| +12% | +$4.44K |
|
3745
Compass Therapeutics
CMPX
$349M
| $37.4K | ﹤0.01% |
37,402
-4,361
| -10% | -$6.37K |
|
|
RAPT
3746
DELISTED
RAPT Therapeutics
RAPT
| $37K | ﹤0.01% |
1,516
-175
| -10% | -$8.08K |
|
3747
Quantum-Si Incorporated
QSI
$157M
| $36.9K | ﹤0.01% |
35,186
-4,888
| -12% | -$7.84K |
|
3748
Tenaya Therapeutics
TNYA
$163M
| $36.7K | ﹤0.01% |
11,848
-78
| -0.7% | -$322 |
|
3749
Verastem
VSTM
$536M
| $36.5K | ﹤0.01% |
+12,260
| New | +$101K |
|
3750
Scilex Holding
SCLX
$46.4M
| $36.3K | ﹤0.01% |
538
| – | – |
|
Similar funds
Invesco's Q2 2024 Portfolio in Review
As of Q2 2024, Invesco held 4,042 positions worth $473B, up 1.6% from $466B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q2 2024 filing shows 191 new, 1,771 increased, 1,786 reduced and 173 closed positions. Its largest new stake was Solventum: 3,404,015 shares worth $180M. The largest sale was NVIDIA, an estimated $649M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2024 buy was Solventum: 3,404,015 shares worth $180M.
- Invesco added most to Apple in Q2 2024, an estimated $1.41B increase.
- Invesco's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $649M.
- Invesco fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $490M.
- Invesco's ten largest holdings make up 18% of its $473B portfolio in Q2 2024.
- Invesco opened 191 new positions and closed 173 in Q2 2024.
- Invesco's portfolio value rose 1.6% quarter-over-quarter to $473B.
Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.